期刊
ANNALS OF GASTROENTEROLOGICAL SURGERY
卷 5, 期 5, 页码 634-638出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/ags3.12465
关键词
colorectal liver metastases; patient selection; two‐ stage hepatectomy
Two-stage hepatectomy is a specific surgical technique for colorectal liver metastases, only suitable for certain patients. While considered effective, not all patients benefit from TSH, highlighting the importance of appropriate patient selection.
Two-stage hepatectomy (TSH) is one of the specific surgical techniques that can expand the pool of resectable patients with initially unresectable colorectal liver metastases (CRLM). The indication of TSH for CRLM is only bilateral, multinodular disease, which cannot be resected by a single hepatectomy. TSH is nowadays considered an effective treatment for selected patients, with acceptable morbidity/mortality rates and promising long-term outcomes. However, not all eligible patients can benefit from the TSH strategy. One of the most important issues is dropout from the strategy (failure to complete both of the two sequential procedures), because the survival of such patients is drastically worse compared with patients who can complete both stages. Another important issue is the early recurrence rate and subsequent poor survival even after completion of TSH. Thus, the selection of appropriate patients who can really benefit from the TSH strategy is crucial. This review discusses the optimal patient selection for TSH, which should be helpful for the development of treatment strategies for patients with extensive CRLM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据